2015 Science Funding Flat

The US legislature passed a spending agreement for next year, and the deal has only modest increases for federal science agencies.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIAThe $1 trillion spending bill passed by Congress last week (December 9) may temporarily avert another government shutdown, but the federal research enterprise didn’t fare too well in the deal. The National Institutes of Health’s (NIH) overall budget was increased by $150 million—a paltry 0.5 percent increase over last year’s $29.9 billion budget. “We appreciate any increase, but it’s not getting the job done,” Jennifer Zeitzer, deputy director of the Federation of American Societies for Experimental Biology’s Office of Public Affairs, told ScienceInsider. “We’re going backwards.”

Another federal science agency did get a slight budgetary boost over last year. The National Science Foundation, for example, would get 2.4 percent more than its 2014 budget, bringing its total funding to $7.3 billion. And the US Food and Drug Administration (FDA) would get $25 million of the $5 billion earmarked for emergency Ebola funding in the bill. The agency would likely put that money toward Ebola drug and vaccine evaluation.

Some other glimmers of hope for science in the bill include a $25 million increase for the Obama administration’s BRAIN initiative, $12.6 million for a new pediatric research initiative, and a $28.6 million increase for the National Institute on Aging.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies